Hepatitis C reinfection in former and active injecting drug users in Belgium
Background: There is currently no systematic screening for hepatitis C (HCV) reinfection in people who inject drugs (PWID) after treatment in Belgium. However, in a recent meta-analysis, the overall HCV reinfection rate was 5.9/100 person-years (PY) among PWID. Accordingly, this study was undertaken to investigate the reinfection rate in former and active PWID who achieved the end of treatment response after direct-acting antiviral (DAA) treatment in Belgium.Methods: This observational cross-sectional study recruited individuals with a history of injecting drug use who had achieved the end of... Mehr ...
| Verfasser: | |
|---|---|
| Dokumenttyp: | Artikel |
| Erscheinungsdatum: | 2021 |
| Reihe/Periodikum: | Busschots , D , Bielen , R , Koc , O M , Heyens , L , Verrando , R , de Galocsy , C , Van Steenkiste , C , Nevens , F , Midgard , H , Dalgard , O & Robaeys , G 2021 , ' Hepatitis C reinfection in former and active injecting drug users in Belgium ' , Harm Reduction Journal , vol. 18 , no. 1 , 102 . https://doi.org/10.1186/s12954-021-00552-x |
| Schlagwörter: | Reinfection / Hepatitis C virus / People who inject drugs / Direct-acting antivirals / HCV INFECTION / PREVALENCE / FRANCE |
| Sprache: | Englisch |
| Permalink: | https://search.fid-benelux.de/Record/base-26597388 |
| Datenquelle: | BASE; Originalkatalog |
| Powered By: | BASE |
| Link(s) : | https://cris.maastrichtuniversity.nl/en/publications/d5e7e9b2-a2ff-4df6-92f7-0902a3c36ba1 |
